• Diagnosis​ ​Info​ ​and​ ​General​ ​Questions

  Sarepta Acquires Rights to Gene Therapy Candidate for Limb-Girdle MD

  Posted by MD forums Moderator on May 21, 2019 at 9:11 am

  

  Sarepta Therapeutics is acquiring calpain-3, an investigational gene therapy for the treatment of limb-girdle muscular dystrophy type 2A. Click here to learn more.

  What do you think of this news?

  replied 6 years, 5 months ago 1 Member · 0 Replies
• 0 Replies

Log In to Reply